Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin and Decitabine in Elderly FLT3-Mutated AML
NCT02634827Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Dec 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midostaurin in acute myeloid leukemia (AML), sponsored by Mayo Clinic. Started Dec 2015; status: terminated.
02
Drugs
midostaurin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02634827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634827.